ExLibris header image
SFX Logo
Title: Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Source:

Trends in Neurosciences [0166-2236] Huber, Jason yr:2001


Collapse list of basic services Basic
Full text
Full text available via EZB-NALI5-00465 Elsevier Archive NL
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Chung, Young C. "The role of neuroinflammation on the pathogenesis of Parkinson's disease." BMB Reports 43.4 (2010): 225-32. Link to SFX for this item
2. Boado, R J J. "Up-regulation of blood-brain barrier short-form leptin receptor gene products in rats fed a high fat diet." Journal of neurochemistry 71.4 (1998): 1761-4. Link to Full Text for this item Link to SFX for this item
3. Huber, Tracy A P. "Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations." American journal of physiology. Heart and circulatory physiology 289.2 (2005): -43. Link to SFX for this item
4. Correale, J. "The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting." Autoimmunity 40.2 (2007): 148-60. Link to SFX for this item
5. Imahori, K. "Physiology and pathology of tau protein kinases in relation to Alzheimer's disease." The Journal of biochemistry 121.2 (1997): 179-88. Link to SFX for this item
6. PARDRIDGE, W M M. "RECEPTOR-MEDIATED PEPTIDE-TRANSPORT THROUGH THE BLOOD-BRAIN-BARRIER." Endocrine reviews 7.3 (1986): 314-330. Link to SFX for this item
7. Tansey, Matthew G. "Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention." Neurobiology of disease 37.3 (2009): 510-518. Link to SFX for this item
8. Stolp, H B B. "Review : Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases." Neuropathology and applied neurobiology 35.2 (2009): 132-146. Link to Full Text for this item Link to SFX for this item
9. Stabel, S. "Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells." Current biology 4.12 (1995): 1077-86. Link to Full Text for this item Link to SFX for this item
10. Wersinger, C. "Inflammation and Parkinson's disease." Current drug targets. Inflammation & allergy 1.3 (2002): 221-42. Link to SFX for this item
11. Monahan, A. "Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis." Cell transplantation 17.4 (2008): 363-72. Link to SFX for this item
12. Lucchinetti, Claudia F F. "The immunopathology of multiple sclerosis: an overview." Brain pathology 17.2 (2007): 210-8. Link to Full Text for this item Link to SFX for this item
13. Hawkins, Thomas P T. "Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution." Brain Research 1027.1-2 (2004): 48-58. Link to SFX for this item
14. Mohamed, Islam N. "Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats." Molecular vision 18.150-52 (2012): 1457-1466. Link to Full Text for this item Link to SFX for this item
15. Huber, T P D. "Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression." American journal of physiology. Heart and circulatory physiology 280.3 (2001): 1241-8. Link to SFX for this item
16. Krizbai, István A A. "Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells." Cellular and molecular neurobiology 25.1 (2005): 129-39. Link to SFX for this item
17. Silverberg, Gerald D D. "Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis." Lancet. Neurology 2.8 (2003): 506-11. Link to SFX for this item
18. Elsinga, Philip H H. "PET studies on P-glycoprotein function in the blood-brain barrier: How it affects uptake and binding of drugs within the CNS." Current pharmaceutical design 10.13 (2004): 1493-1503. Link to SFX for this item
19. Pei, J. "Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain." Journal of neuropathology and experimental neurology 56.1 (1997): 70-78. Link to SFX for this item
20. Avila, J. "Tau phosphorylation and aggregation in Alzheimer's disease pathology." FEBS letters 580.12 (2006): 2922-2927. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced